Paul Kerr

Paul Kerr has over 20 years’ experience in the biopharmaceutical industry. He has over 15 years’ experience with Fusion Antibodies, initially in a variety of technical roles followed by eight years in Business Development, where he was responsible for developing the company’s contract research services and seeking partners for the drug assets discovered and validated. Paul has a PhD from Queen’s University Belfast and his previous roles included developing monoclonal antibodies at Queens University Belfast, Veterinary Sciences Division, Stormont laboratory and ELISA development & testing services at Campden BRI, Chipping Campden, Gloucestershire, UK. In 2011, Paul joined Fusion Antibodies as a Director and was appointed as Managing Director.